101 related articles for article (PubMed ID: 25855589)
1. Tissue-type plasminogen activator-binding RNA aptamers inhibiting low-density lipoprotein receptor family-mediated internalisation.
Bjerregaard N; Bøtkjær KA; Helsen N; Andreasen PA; Dupont DM
Thromb Haemost; 2015 Jul; 114(1):139-49. PubMed ID: 25855589
[TBL] [Abstract][Full Text] [Related]
2. The effect of plasmin-mediated degradation on fibrinolysis and tissue plasminogen activator diffusion.
Bannish BE; Paynter B; Risman RA; Shroff M; Tutwiler V
Biophys J; 2024 Mar; 123(5):610-621. PubMed ID: 38356261
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolytic and Non-fibrinolytic Roles of Tissue-type Plasminogen Activator in the Ischemic Brain.
Yepes M
Neuroscience; 2024 Mar; 542():69-80. PubMed ID: 37574107
[TBL] [Abstract][Full Text] [Related]
4. Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts.
Zhalyalov AS; Panteleev MA; Gracheva MA; Ataullakhanov FI; Shibeko AM
PLoS One; 2017; 12(7):e0180668. PubMed ID: 28686711
[TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies.
Adibhatla RM; Hatcher JF
CNS Neurol Disord Drug Targets; 2008 Jun; 7(3):243-53. PubMed ID: 18673209
[TBL] [Abstract][Full Text] [Related]
6. Histone content, and thus DNA content, is associated with differential in vitro lysis of acute ischemic stroke clots.
Akkipeddi SMK; Rahmani R; Ellens NR; Kohli GS; Houk C; Schartz DA; Chittaranjan S; Worley L; Gunturi A; Bhalla T; Mattingly TK; Welle K; Morrell CN; Bender MT
J Thromb Haemost; 2024 May; 22(5):1410-1420. PubMed ID: 38296159
[TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C.
Liu D; Cheng T; Guo H; Fernández JA; Griffin JH; Song X; Zlokovic BV
Nat Med; 2004 Dec; 10(12):1379-83. PubMed ID: 15516929
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Characterization of Tissue Plasminogen Activator-Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot Dissolution.
Heid S; Unterweger H; Tietze R; Friedrich RP; Weigel B; Cicha I; Eberbeck D; Boccaccini AR; Alexiou C; Lyer S
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837060
[TBL] [Abstract][Full Text] [Related]
9. The annexin A2 system and vascular homeostasis.
Flood EC; Hajjar KA
Vascul Pharmacol; 2011; 54(3-6):59-67. PubMed ID: 21440088
[TBL] [Abstract][Full Text] [Related]
10. Identification of potent anti-fibrinolytic compounds against plasminogen and tissue-type plasminogen activator employing
Banerjee S; Mahesh Y; Prabhu D; Sekar K; Sen P
J Biomol Struct Dyn; 2024 Apr; 42(6):3204-3222. PubMed ID: 37216286
[TBL] [Abstract][Full Text] [Related]
11. Magnetically powered microwheel thrombolysis of occlusive thrombi in zebrafish.
Pontius MHH; Ku CJ; Osmond MJ; Disharoon D; Liu Y; Warnock M; Lawrence DA; Marr DWM; Neeves KB; Shavit JA
Proc Natl Acad Sci U S A; 2024 Mar; 121(10):e2315083121. PubMed ID: 38408253
[TBL] [Abstract][Full Text] [Related]
12. Parabiosis Discriminates the Circulating, Endothelial, and Parenchymal Contributions of Endogenous Tissue-Type Plasminogen Activator to Stroke.
Furon J; Lebrun F; Yétim M; Levard D; Marie P; Orset C; Martinez de Lizarrondo S; Vivien D; Ali C
Stroke; 2024 Mar; 55(3):747-756. PubMed ID: 38288607
[TBL] [Abstract][Full Text] [Related]
13. Tissue-type plasminogen activator regulates macrophage activation and innate immunity.
Mantuano E; Azmoon P; Brifault C; Banki MA; Gilder AS; Campana WM; Gonias SL
Blood; 2017 Sep; 130(11):1364-1374. PubMed ID: 28684538
[TBL] [Abstract][Full Text] [Related]
14. The role of endogenous tissue-type plasminogen activator in neuronal survival after ischemic stroke: friend or foe?
Zhu J; Wan Y; Xu H; Wu Y; Hu B; Jin H
Cell Mol Life Sci; 2019 Apr; 76(8):1489-1506. PubMed ID: 30656378
[TBL] [Abstract][Full Text] [Related]
15. Impact of SMTP Targeting Plasminogen and Soluble Epoxide Hydrolase on Thrombolysis, Inflammation, and Ischemic Stroke.
Hasumi K; Suzuki E
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477998
[No Abstract] [Full Text] [Related]
16. Plasmin-loaded echogenic liposomes for ultrasound-mediated thrombolysis.
Kandadai MA; Meunier JM; Hart K; Holland CK; Shaw GJ
Transl Stroke Res; 2015 Feb; 6(1):78-87. PubMed ID: 25411015
[TBL] [Abstract][Full Text] [Related]
17. In vitro investigations into enhancement of tPA bioavailability in whole blood clots using pulsed-high intensity focused ultrasound exposures.
Jones G; Hunter F; Hancock HA; Kapoor A; Stone MJ; Wood BJ; Xie J; Dreher MR; Frenkel V
IEEE Trans Biomed Eng; 2010 Jan; 57(1):33-6. PubMed ID: 20064753
[TBL] [Abstract][Full Text] [Related]
18. Release of IL-6 After Stroke Contributes to Impaired Cerebral Autoregulation and Hippocampal Neuronal Necrosis Through NMDA Receptor Activation and Upregulation of ET-1 and JNK.
Armstead WM; Hekierski H; Pastor P; Yarovoi S; Higazi AA; Cines DB
Transl Stroke Res; 2019 Feb; 10(1):104-111. PubMed ID: 29476447
[TBL] [Abstract][Full Text] [Related]
19. An antibody that targets cell-surface glucose-regulated protein-78 inhibits expression of inflammatory cytokines and plasminogen activator inhibitors by macrophages.
Gunner CB; Azmoon P; Mantuano E; Das L; Zampieri C; Pizzo SV; Gonias SL
J Cell Biochem; 2023 May; 124(5):743-752. PubMed ID: 36947703
[TBL] [Abstract][Full Text] [Related]
20. Influence of the 3K3A-activated protein C variant on the plasma clot lysis activity of t-PA and of t-PA on the variant's anticoagulant activity.
Mosnier LO; Fernández JA; Davis TP; Zlokovic BV; Griffin JH
J Thromb Haemost; 2013 Nov; 11(11):2059-62. PubMed ID: 24034518
[No Abstract] [Full Text] [Related]
[Next] [New Search]
